![Marc Rochat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Marc Rochat
Entité | Type d'entité | Industrie | |
---|---|---|---|
Covalence SA (Switzerland)
![]() Covalence SA (Switzerland) Investment ManagersFinance Covalence SA is an independent Swiss investment research firm which was co-founded by Antoine Mach and Marc Rochat in 2001. Headquartered in Carouge, the firm delivers data and research to corporates, academics and non-profits relying on its EthicalQuote reputation index. Their services includes ESG ratings, ESG news data, portfolio advisory, and impact stories, and support sustainable and responsible investment, ESG integration and impact investing strategies. Covalence is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI).
3
| Private Company | Investment Managers | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Marc Rochat via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Geneva | College/University | Doctorate Degree Graduate Degree | |
Lifespan, Inc.
![]() Lifespan, Inc. Medical/Nursing ServicesHealth Services Lifespan, Inc. provides healthcare services. The company was founded on January 27, 1997 and is headquartered in Palm Desert, CA. | Medical/Nursing Services | Director/Board Member | |
Aerium Therapeutics, Inc.
![]() Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member | |
Luxe Trading SA | Director/Board Member | ||
OMEGA ALPHA SPAC | Financial Conglomerates | Founder | |
FoRx Therapeutics AG
![]() FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Pictet - Biotech | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immunic AG
![]() Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
RainDance Technologies, Inc.
![]() RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
NeoMed S.à.r.l. | Investment Managers | Private Equity Investor | |
Andrew Alliance SA
![]() Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland. | Industrial Machinery | Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member | |
KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
SOPHIA GENETICS SA | Packaged Software | Director/Board Member | |
Pictet Bank & Trust Ltd. (Private Banking)
![]() Pictet Bank & Trust Ltd. (Private Banking) Investment ManagersFinance Pictet Bank & Trust Ltd. (Private Banking) (Pictet Bank & Trust-PB) is the private banking arm of Pictet Bank & Trust Ltd., an offshore bank headquartered in Nassau, Bahamas. The firm was founded in 1978 and is a subsidiary of Banque Pictet & Cie SA, a Swiss private bank which specializes in asset and wealth management. Pictet Bank & Trust-PB provides wealth management and asset servicing for private clients. | Investment Managers | Corporate Officer/Principal | |
Omega Fund Management LLC
![]() Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor | |
Sustainable Finance Geneva
![]() Sustainable Finance Geneva Miscellaneous Commercial ServicesCommercial Services Sustainable Finance Geneva operates as an association that establishes Geneva as the centre for innovation in sustainable finance by engaging individuals and harnessing collective intelligence. The company was founded by Etienne Eichenberger, Jean Yves Daniel Laville, Antoine Mach, Angela de Wolff, Philippe Spicher, Vincent Dufresne, Natacha Guerdat, Olivier Fruchaud, Cédric Lombard, Guillaume Taylor, Elizabeth Umlas, Paul Clements-Hunt, Roland Widmer, Remco Fischer, Antoine Melo and Cheryl Hicks in 2008 and is headquartered in Geneva, Switzerland. | Miscellaneous Commercial Services | Founder |
Statistiques
Internationale
Suisse | 10 |
Etats-Unis | 8 |
Canada | 2 |
Luxembourg | 2 |
Allemagne | 2 |
Sectorielle
Health Technology | 9 |
Finance | 6 |
Miscellaneous | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Opérationnelle
Director/Board Member | 14 |
Founder | 3 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Private Equity Investor | 2 |
Relations les plus connectées
Insiders | |
---|---|
Vincent Ossipow | 22 |
Antoine Mach | 3 |
Silvia Ceria | 1 |
- Bourse
- Insiders
- Marc Rochat
- Connexions Sociétés